Four years ago, Qualitest Pharmaceuticals issued a recall for a birth control packaging error affecting more than 1.4 million products. The manufacturers mistakenly and unknowingly reversed the weekly pill order; thereby making the birth control tablets ineffective (birth control pills must be taken in the correct order for it to work).
So far, 113 women have since stepped forward to file lawsuits against the pharmaceutical company, claiming that its mistake directly resulted in unwanted pregnancies in all but four of the women. Most are seeking damages for medical expenses and lost wages, but some are pursuing pain and suffering and even money for raising a child for 18 years. The total damages being sought is well into the millions.
The women have filed a class action suit against Endo Pharmaceuticals, Qualitest’s parent company, in Pennsylvania. Endo responded with a statement asking the judge to dismiss the case as previous lawsuits regarding the 2011 recall were dismissed due to lack of evidence.
Class Action Lawsuits Against Big Pharma
Filing a class action suit against large companies such as pharmaceutical companies greatly improved the plaintiffs’ odds of reaching a settlement because it allows all of the plaintiffs to work together, pooling resources and sharing evidence.
All of these women put their trust in Qualitest and its parent company Endo, but that faith was rewarded with allegedly defective products and the unwillingness to admit fault. When a manufacturing defect like this puts an unmeasurable amount of burden on these women’s lives, the pharmaceutical company should take responsibility.